Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

5 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
March 23, 2018 ECVT P 15,000 $14.39 $215,850 85,713 Direct +21.21% Acquired -27.9% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Oct. 2, 2017 ECVT Stock Option (right to buy) Common Stock (55,762) $16.97 Oct. 2, 2027 55,762 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ECVT

Vice President and President, Performance Chemicals(2)
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2019 $400,000 · $1,000,001 · $221,171 · $545,500 $2,166,672
2018 $460,000 · · · $234,210 · $30,433 $724,643
2017 $133,333 · · · $45,833 · $4,289 $1,683,455

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.